Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Inactivated e.coli (antigen k99), Inactivated e.coli (antigen y), Inactivated e.coli (antigen 31a), Inactivated e.coli serotype 09, Inactivated e.coli serotype 08, Inactivated e.coli serotype 015, Inactivated e.coli serotype 078, Inactivated e.coli serotype 0101, Inactivated e.coli serotype 00117
Merial Animal Health Limited
QI02AC
Inactivated e.coli (antigen k99), Inactivated e.coli (antigen y), Inactivated e.coli (antigen 31a), Inactivated e.coli serotype
percent
Suspension for injection
LM: Licensed Merchant as defined in relevant national legislation
Cattle, Sheep
Inactivated bacterial vaccines and antisera QI04AC Inactivated bacterial vaccines and antisera
Immunological - Inactivated Vaccine
Authorised
2003-08-06
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10857/033/001 Case No: 7004886 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: MERIAL ANIMAL HEALTH LIMITED SANDRINGHAM HOUSE , SANDRINGHAM AVENUE, HARLOW BUSINESS PARK, HARLOW , ESSEX CM19 5TG , UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: IMOCOLIBOV The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation,unless revoked, shall continue in force from 22/09/2008 . Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _3_ _/_ _0_ _9_ _/_ _2_ _0_ _0_ _8_ _C_ _R_ _N_ _ _ _7_ _0_ _0_ _4_ _8_ _8_ _6_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT IMOCOLIBOV 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of vaccine contains_ E. coli_ somatic serotypes 09, 08, 015, 078, 0101, 0117, expressi Read the complete document